Dataset Information

Survival prediction in triple negative breast cancer using multiple instance learning of histopathological images.

ABSTRACT: Computational pathology is a rapidly expanding area for research due to the current global transformation of histopathology through the adoption of digital workflows. Survival prediction of breast cancer patients is an important task that currently depends on histopathology assessment of cancer morphological features, immunohistochemical biomarker expression and patient clinical findings. To facilitate the manual process of survival risk prediction, we developed a computational pathology framework for survival prediction using digitally scanned haematoxylin and eosin-stained tissue microarray images of clinically aggressive triple negative breast cancer. Our results show that the model can produce an average concordance index of 0.616. Our model predictions are analysed for independent prognostic significance in univariate analysis (hazard ratio = 3.12, 95% confidence interval [1.69,5.75], p < 0.005) and multivariate analysis using clinicopathological data (hazard ratio = 2.68, 95% confidence interval [1.44,4.99], p < 0.005). Through qualitative analysis of heatmaps generated from our model, an expert pathologist is able to associate tissue features highlighted in the attention heatmaps of high-risk predictions with morphological features associated with more aggressive behaviour such as low levels of tumour infiltrating lymphocytes, stroma rich tissues and high-grade invasive carcinoma, providing explainability of our method for triple negative breast cancer.

SUBMITTER: Sandarenu P

PROVIDER: S-EPMC9411153 | biostudies-literature | 2022 Aug

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Survival prediction in triple negative breast cancer using multiple instance learning of histopathological images.

Sandarenu Piumi P Millar Ewan K A EKA Song Yang Y Browne Lois L Beretov Julia J Lynch Jodi J Graham Peter H PH Jonnagaddala Jitendra J Hawkins Nicholas N Huang Junzhou J Meijering Erik E

Scientific reports 20220825 1

Computational pathology is a rapidly expanding area for research due to the current global transformation of histopathology through the adoption of digital workflows. Survival prediction of breast cancer patients is an important task that currently depends on histopathology assessment of cancer morphological features, immunohistochemical biomarker expression and patient clinical findings. To facilitate the manual process of survival risk prediction, we developed a computational pathology framewo ...[more]

PMID: 36008541

Similar Datasets

Project description:In the context of drug discovery and development, much effort has been exerted to determine which conformers of a given molecule are responsible for the observed biological activity. In this work we aimed to predict bioactive conformers using a variant of supervised learning, named multiple-instance learning. A single molecule, treated as a bag of conformers, is biologically active if and only if at least one of its conformers, treated as an instance, is responsible for the observed bioactivity; and a molecule is inactive if none of its conformers is responsible for the observed bioactivity. The implementation requires instance-based embedding, and joint feature selection and classification. The goal of the present project is to implement multiple-instance learning in drug activity prediction, and subsequently to identify the bioactive conformers for each molecule.We encoded the 3-dimensional structures using pharmacophore fingerprints which are binary strings, and accomplished instance-based embedding using calculated dissimilarity distances. Four dissimilarity measures were employed and their performances were compared. 1-norm SVM was used for joint feature selection and classification. The approach was applied to four data sets, and the best proposed model for each data set was determined by using the dissimilarity measure yielding the smallest number of selected features.The predictive abilities of the proposed approach were compared with three classical predictive models without instance-based embedding. The proposed approach produced the best predictive models for one data set and second best predictive models for the rest of the data sets, based on the external validations. To validate the ability of the proposed approach to find bioactive conformers, 12 small molecules with co-crystallized structures were seeded in one data set. 10 out of 12 co-crystallized structures were indeed identified as significant conformers using the proposed approach.The proposed approach was proven not to suffer from overfitting and to be highly competitive with classical predictive models, so it is very powerful for drug activity prediction. The approach was also validated as a useful method for pursuit of bioactive conformers.

Project description:Providing prognostic information at the time of cancer diagnosis has important implications for treatment and monitoring. Although cancer staging, histopathological assessment, molecular features, and clinical variables can provide useful prognostic insights, improving risk stratification remains an active research area. We developed a deep learning system (DLS) to predict disease specific survival across 10 cancer types from The Cancer Genome Atlas (TCGA). We used a weakly-supervised approach without pixel-level annotations, and tested three different survival loss functions. The DLS was developed using 9,086 slides from 3,664 cases and evaluated using 3,009 slides from 1,216 cases. In multivariable Cox regression analysis of the combined cohort including all 10 cancers, the DLS was significantly associated with disease specific survival (hazard ratio of 1.58, 95% CI 1.28-1.70, p<0.0001) after adjusting for cancer type, stage, age, and sex. In a per-cancer adjusted subanalysis, the DLS remained a significant predictor of survival in 5 of 10 cancer types. Compared to a baseline model including stage, age, and sex, the c-index of the model demonstrated an absolute 3.7% improvement (95% CI 1.0-6.5) in the combined cohort. Additionally, our models stratified patients within individual cancer stages, particularly stage II (p = 0.025) and stage III (p<0.001). By developing and evaluating prognostic models across multiple cancer types, this work represents one of the most comprehensive studies exploring the direct prediction of clinical outcomes using deep learning and histopathology images. Our analysis demonstrates the potential for this approach to provide significant prognostic information in multiple cancer types, and even within specific pathologic stages. However, given the relatively small number of cases and observed clinical events for a deep learning task of this type, we observed wide confidence intervals for model performance, thus highlighting that future work will benefit from larger datasets assembled for the purposes for survival modeling.

Project description:Breast cancer is associated with the highest morbidity rates for cancer diagnoses in the world and has become a major public health issue. Early diagnosis can increase the chance of successful treatment and survival. However, it is a very challenging and time-consuming task that relies on the experience of pathologists. The automatic diagnosis of breast cancer by analyzing histopathological images plays a significant role for patients and their prognosis. However, traditional feature extraction methods can only extract some low-level features of images, and prior knowledge is necessary to select useful features, which can be greatly affected by humans. Deep learning techniques can extract high-level abstract features from images automatically. Therefore, we introduce it to analyze histopathological images of breast cancer via supervised and unsupervised deep convolutional neural networks. First, we adapted Inception_V3 and Inception_ResNet_V2 architectures to the binary and multi-class issues of breast cancer histopathological image classification by utilizing transfer learning techniques. Then, to overcome the influence from the imbalanced histopathological images in subclasses, we balanced the subclasses with Ductal Carcinoma as the baseline by turning images up and down, right and left, and rotating them counterclockwise by 90 and 180 degrees. Our experimental results of the supervised histopathological image classification of breast cancer and the comparison to the results from other studies demonstrate that Inception_V3 and Inception_ResNet_V2 based histopathological image classification of breast cancer is superior to the existing methods. Furthermore, these findings show that Inception_ResNet_V2 network is the best deep learning architecture so far for diagnosing breast cancers by analyzing histopathological images. Therefore, we used Inception_ResNet_V2 to extract features from breast cancer histopathological images to perform unsupervised analysis of the images. We also constructed a new autoencoder network to transform the features extracted by Inception_ResNet_V2 to a low dimensional space to do clustering analysis of the images. The experimental results demonstrate that using our proposed autoencoder network results in better clustering results than those based on features extracted only by Inception_ResNet_V2 network. All of our experimental results demonstrate that Inception_ResNet_V2 network based deep transfer learning provides a new means of performing analysis of histopathological images of breast cancer.

Dataset Information

Survival prediction in triple negative breast cancer using multiple instance learning of histopathological images.

Publications

Survival prediction in triple negative breast cancer using multiple instance learning of histopathological images.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets